Starlix (nateglinide), a new oral tablet for type 2 diabetes

Novartis is now marketing Starlix (nateglinide), a new oral tablet for type 2 diabetes.

Think of it as a shorter-acting GlucoNorm (repaglinide).

Both meds are taken before meals to stimulate insulin release...but Starlix has a shorter duration.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote